Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.53 |
| ▸ | HTR3B | O95264 | 1/20 | 0.53 |
| ▸ | HTR3A | P46098 | 1/20 | 0.53 |
| ▸ | HTR3D | Q70Z44 | 1/20 | 0.53 |
| ▸ | HTR3C | Q8WXA8 | 1/20 | 0.53 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29600721 | 1.00 | HTR3E (0.53) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL893938 | 0.86 | CYP3A4 (0.49) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL17874342 | 0.86 | FDPS (0.49) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL31711475 | 0.86 | CYP3A4 (0.42) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL17027575 | 0.86 | MAPT (0.50) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL11184869 | 0.85 | TSHR (0.54) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL543088 | 0.85 | CYP3A4 (0.71) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL29800238 | 0.85 | CYP3A4 (0.71) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL124245 | 0.85 | CYP3A4 (0.59) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL29510769 | 0.85 | CYP3A4 (0.59) | HTR3EHTR3BHTR3AHTR3DHTR3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 312 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116445053-B | Preparation method of strong-binding high-corrosion-resistance coating | 浙江飞鲸新材料科技股份有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-116445053-A | Preparation method of strong-binding high-corrosion-resistance coating | 浙江飞鲸新材料科技股份有限公司 | 2023-07-18 | — | — | CN | claimed |
| CN-114068065-B | Conductive material for temperature sensor and use thereof | 杭州安誉科技有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114068065-A | Conductive material for temperature sensor and use thereof | 杭州安誉科技有限公司 | 2022-02-18 | — | — | CN | claimed |
| CN-112967834-A | Conductive material for temperature sensor and use thereof | 杭州安誉科技有限公司 | 2021-06-15 | — | — | CN | claimed |
| CN-112321523-B | Preparation method and application of oxazolone compound capable of inhibiting bacteria in patient care process | 河南科技大学第一附属医院 | 2021-04-30 | — | — | CN | claimed |
| CN-112321523-A | Preparation method and application of oxazolone compound capable of inhibiting bacteria in patient care process | 河南科技大学第一附属医院 | 2021-02-05 | — | — | CN | claimed |
| CN-111559985-A | Oxazolone compound with bactericidal effect and preparation method thereof | 河南科技大学第一附属医院 | 2020-08-21 | — | — | CN | claimed |
| WO-2026105118-A1 | COMPOUNDS USABLE AS MODULATORS OF PERK ACTIVITY | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2026-05-21 | — | — | WO | disclosed |
| EP-4713378-A1 | ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS | Covestro Deutschland AG (DE) | 2026-03-25 | — | — | EP | disclosed |
| US-12338226-B2 | Substituted benzodiazoles and use thereof in therapy | THOMAS HELLEDAYS STIFTELSE FOR MEDICINSK FORSKNING (SE) | 2025-06-24 | — | — | US | disclosed |
| EP-3774961-B1 | ADDUCTS OF AMINE CATALYSTS FOR PRODUCING ISOCYANURATE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2025-01-15 | — | — | EP | disclosed |
| WO-2024236000-A1 | ESTERIFIED ETHANOLAMINES FOR PREPARING ISOCYANURATE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2024-11-21 | — | — | WO | disclosed |
| EP-4464727-A1 | ESTERIFIED ETHANOLAMINES FOR THE PREPARATION OF ISOCYANURATE POLYMERS | Covestro Deutschland AG (DE) | 2024-11-20 | — | — | EP | disclosed |
| US-4098788-A | Process for preparing quinazolines | BRISTOL-MYERS COMPANY (US) | 1978-07-04 | — | — | US | disclosed |
| US-4088766-A | PRODUCTION OF PROSTAGLANDINS IN MAMMALS | THE UPJOHN COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
| US-4046909-A | Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants | MCNEIL LABORATORIES, INCORPORATED (US) | 1977-09-06 | — | — | US | disclosed |
| US-4001256-A | PROSTAGLANDIN PRODUCTION IN MAMMALS | THE UPJOHN COMPANY (US) | 1977-01-04 | — | — | US | disclosed |
| US-3998958-A | Pyrrolidylidene, piperidylidene and hexahydroazepinylidene ureas as CNS depressants | MCNEIL LABORATORIES, INCORPORATED (US) | 1976-12-21 | — | — | US | disclosed |
| US-3991064-A | Benzonaphthyridines | WARNER-LAMBERT COMPANY (US) | 1976-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12338226-B2 | Substituted benzodiazoles and use thereof in therapy | XDH, CYP11B2, CYP4X1 | HTR3E 972/4885HTR3B 763/4885HTR3A 938/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.